Evidence map›Paper›PMID 34288548›Full record

ArticlePhysiological reports2021

Can selenium-enriched spirulina supplementation ameliorate sepsis outcomes in selenium-deficient animals?

Thomas Castel, Michaël Theron, Karine Pichavant-Rafini, Anthony Guernec, Aurélie Joublin-Delavat, Bleuenn Gueguen, Karelle Leon

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Biochemical Profile ofPlants (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thomas CastelUniversité de Brest, EA 4324 ORPHY, UFR Sciences et Techniques, Brest, France.ORCID 0000-0003-4339-8859
Michaël TheronUniversité de Brest, EA 4324 ORPHY, UFR Sciences et Techniques, Brest, France.
Karine Pichavant-RafiniUniversité de Brest, EA 4324 ORPHY, UFR Sciences et Techniques, Brest, France.
Anthony GuernecUniversité de Brest, EA 4324 ORPHY, UFR Sciences et Techniques, Brest, France.
Aurélie Joublin-DelavatUniversité de Brest, EA 4324 ORPHY, UFR Sciences et Techniques, Brest, France.
Bleuenn GueguenCNRS, Univ Brest, UMS 3113, Plouzané, France.
Karelle LeonUniversité de Brest, EA 4324 ORPHY, UFR Sciences et Techniques, Brest, France.
Université de Bretagne Occidentale · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In intensive care units, sepsis is the first cause of death. In this pathology, inflammation and oxidative status play a crucial role in patient outcomes. Interestingly, 92% of septic patients exhibit low selenium plasma concentrations (a component of antioxidant enzymes). Moreover, Spirulina platensis, a blue-green algae, demonstrated anti-inflammatory effects. In this context, the main purpose of our study was to analyze the effect of a selenium-enriched spirulina after a selenium deficiency on sepsis outcome in rats. Sixty-four rats were fed 12 weeks with a selenium-deficient food. After 8 weeks, rats were supplemented (via drinking water) for 4 weeks with sodium selenite (Se), spirulina (Spi), or selenium-enriched spirulina (SeSp). Sepsis was then induced by cecal ligature and puncture, and survival duration was observed. The plasma selenium concentration was measured by ICPMS. Expression of GPx1 and GPx3 mRNA was measured by RT-PCR. Blood parameters (lactates and HCO

Indexed as

Dietary SupplementsSpirulinaAnimalsAntioxidantsFemaleInflammation MediatorsRatsRats, WistarSeleniumSepsisAntioxidantsInflammation MediatorsSeleniumGPxlactatesseleniumsepsisSpirulinasupplementation

Identifiers

PMID34288548
PMCPMC8290477
OpenAlexW3183398489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.